ResearcherSpanish National Cancer Research CentreNo recent work listed
Anamaria Balic
Matched on ORCID iD 0000-0001-6796-1197; OpenAlex author ID A5080784515. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper
Papers 5
- Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Co-author DOI 10.1158/1535-7163.mct-13-0948↗
- Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. Co-author DOI 10.1371/journal.pone.0066371↗
- Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. Co-author DOI 10.1371/journal.pone.0076518↗
- Stem cells as the root of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.yexcr.2011.11.007↗
- Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Co-author DOI 10.1016/j.stem.2011.10.001↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher Heeschen · 5 shared papers, 2011–2014 · strength 0.17
- Paper Stem cells as the root of pancreatic ductal adenocarcinoma. DOI 10.1016/j.yexcr.2011.11.007↗
- Paper Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. DOI 10.1158/1535-7163.mct-13-0948↗
- Paper Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. DOI 10.1371/journal.pone.0076518↗
- Manuel M. Hidalgo · 4 shared papers, 2011–2014 · strength 0.13
- Paper Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. DOI 10.1158/1535-7163.mct-13-0948↗
- Paper Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. DOI 10.1371/journal.pone.0076518↗
- Paper Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Ti… DOI 10.1371/journal.pone.0066371↗
- Sara Maria David Trabulo · 3 shared papers, 2013–2014 · strength 0.11
- Paper Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. DOI 10.1158/1535-7163.mct-13-0948↗
- Paper Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. DOI 10.1371/journal.pone.0076518↗
- Paper Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Ti… DOI 10.1371/journal.pone.0066371↗
- Jorge Dorado · 2 shared papers, 2012–2013 · strength 0.08
- Michele Cioffi · 2 shared papers, 2013–2014 · strength 0.08
- Bruno Sáinz · 2 shared papers, 2013–2014 · strength 0.07
- Enza Lonardo · 2 shared papers, 2011–2013 · strength 0.06
- Patrick Christian Hermann · 2 shared papers, 2011–2013 · strength 0.05
- Paper Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Ti… DOI 10.1371/journal.pone.0066371↗
- Paper Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target fo… DOI 10.1016/j.stem.2011.10.001↗
- Mert Erkan · 1 shared paper, 2014 · strength 0.04
- Jorg H. Kleeff · 1 shared paper, 2014 · strength 0.04
- Patricia Sancho Andrés · 1 shared paper, 2013 · strength 0.04
- Annette C. Bakker · 1 shared paper, 2013 · strength 0.03
- Sanjeeb Kumar Sahoo · 1 shared paper, 2013 · strength 0.03
- Stephan A. Hahn · 1 shared paper, 2013 · strength 0.03
- Sladjana Zagorac · 1 shared paper, 2011 · strength 0.02
- Rainer Lothar Heuchel · 1 shared paper, 2011 · strength 0.02
- Sonia Alcalá · 1 shared paper, 2011 · strength 0.02
- Matthias J. Löhr · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.